scholarly journals Cost of hypertension illness and associated factors among patients attending hospitals in Southwest Shewa Zone, Oromia Regional State, Ethiopia

2019 ◽  
Author(s):  
Addisu Bogale ◽  
Teferi Daba ◽  
Dawit Wolde Daka
Keyword(s):  
Linear Regression Analysis ◽  
Indirect Costs ◽  
Total Direct Cost ◽  
Multivariate Linear Regression Analysis ◽  
Total Cost ◽  
Direct And Indirect Costs ◽  
Regional State ◽  
The Mean ◽  
The Cost ◽  
The Impact

AbstractBackgroundHypertension is a common vascular disease and the main risk factor for cardiovascular diseases. The impact of hypertension is on the rise in Ethiopia, so that, it is predictable that the cost of healthcare services will further increase in the future. We aimed to estimate the total cost of hypertension illness among patients attending hospitals in Southwest Shewa zone, Oromia Regional State, Ethiopia.Patients and methodsInstitution based cross-sectional study was conducted from July 1-30, 2018. All hypertensive patients who were on treatment and whose age was greater than eighteen years old were eligible for this study. The total cost of hypertension illness was estimated by summing up the direct and indirect costs. Bivariate and multivariate linear regression analysis was conducted to identify factors associated with hypertension costs of illness.ResultsOverall, the mean monthly total cost of hypertension illness was US $ 22.3 (95% CI, 21.3-23.3). Direct and indirect costs share 51% and 49% of the total cost, respectively. The mean total direct cost of hypertension illness per patient per month was US $11.39(95% CI, 10.6-12.1). Out of these, drugs accounted of a higher cost (31%) followed by food (25%). The mean total indirect cost per patient per month was US $10.89(95% CI, 10.4-11.4). Educational status, distance from hospital, the presence of companion and the stage of hypertension were predictors of the cost of illness of hypertension.ConclusionThe cost of hypertension illness was very high when compared with the mean monthly income of the patients letting patients to catastrophic costs. Therefore, due attention should be given by the government to protect patients from financial hardships.

The Economic Cost of Suicide in Ireland

Crisis ◽  
2007 ◽  
Vol 28 (2) ◽  
pp. 89-94 ◽  
Author(s):  
Brendan Kennelly
Keyword(s):  
Gross National Product ◽  
Indirect Costs ◽  
Economic Cost ◽  
Economic Costs ◽  
Total Cost ◽  
Direct And Indirect Costs ◽  
Education And Health ◽  
Human Cost ◽  
Human Costs ◽  
The Cost

Abstract. Objective: To calculate the costs of suicide in Ireland. Method: The paper identifies all episodes of suicide in Ireland in 2001 and 2002, and projects the economic costs arising from these episodes over subsequent years. All prices have been converted to 2001 euros. Both direct and indirect costs were calculated. Indirect costs included both the cost of lost output and human costs. Results: The total cost of suicide is estimated at over Euro 906 million in 2001, and over Euro 835 million in 2002 (in 2001 prices). This is equivalent to a little under 1% of the gross national product in Ireland for those years. Conclusions: The results show that investment in health education and health promotion can be justified on the basis of the costs associated with suicide in Ireland. These costs fall on individuals, families, and society. The huge human cost of suffering associated with suicide can also be prevented through appropriate intervention to prevent death occurring. It is important that any suicide prevention strategy should include an evaluative framework to ensure that investment occurs in the areas most likely to generate the highest returns in term of suicides prevented and lives saved.

The impact of maternal cortisol concentrations on child arterial elasticity

2010 ◽  
Vol 2 (1) ◽  
pp. 56-62 ◽  
Author(s):  
P. H. C. Rondó ◽  
J. A. Pereira ◽  
J. O. Lemos ◽  
R. F. Ferreira
Keyword(s):  
Linear Regression Analysis ◽  
Epidemiological Studies ◽  
The Body ◽  
Multivariate Linear Regression Analysis ◽  
Large Artery ◽  
Model Assessment ◽  
Arterial Elasticity ◽  
The Mean ◽  
The Impact ◽  
Mean Concentration

Epidemiological studies suggest that glucocorticoid excess in the fetus may contribute to the pathophysiology of cardiovascular diseases in adulthood. However, the impact of maternal glucocorticoid on the cardiovascular system of the offspring has not been much explored in studies involving humans, especially in childhood. The objective of this study was to assess the influence of maternal cortisol concentrations on child arterial elasticity. One hundred and thirty pregnant women followed from 1997 to 2000, and respective children 5–7 years of age followed from 2004 to 2006 were included in the study. Maternal cortisol was determined in saliva by an enzyme immunoassay utilizing the mean concentration of nine samples of saliva. Arterial elasticity was assessed by the large artery elasticity index (LAEI; the capacitive elasticity of large arteries) by recording radial artery pulse wave, utilizing the equipment HDI/PulseWave CR-2000 Cardiovascular Profiling System®. The nutritional status of the children was determined by the body mass index (BMI). Insulin concentration was assessed by chemiluminescence, and insulin resistance by the homeostasis model assessment. Blood glucose, total cholesterol and fractions (LDL-c and HDL-c) and triglyceride concentrations were determined by automated enzymatic methods. The association between maternal cortisol and child arterial elasticity was assessed by multivariate linear regression analysis. There was a statistically significant association between maternal cortisol and LAEI (P= 0.02), controlling for birth weight, age, BMI and HDL-c of the children. This study suggests that exposure to higher glucocorticoid concentrations in the prenatal period is associated to lower arterial elasticity in childhood, an earlier cardiovascular risk marker.

Cost of depression: effect of adherence and treatment response

2006 ◽  
Vol 21 (6) ◽  
pp. 349-354 ◽  
Author(s):  
L. von Knorring ◽  
A.-C. Åkerblad ◽  
F. Bengtsson ◽  
Å. Carlsson ◽  
L. Ekselius
Keyword(s):  
Quality Of Life ◽  
Major Depression ◽  
Treatment Response ◽  
Controlled Trial ◽  
Indirect Costs ◽  
The Mean ◽  
Cost Of Drugs ◽  
The Cost ◽  
The Impact

AbstractObjectives:The purpose of the present study has been to assess the societal cost of major depression and the distribution into different cost components. The impact of adherence and treatment response was also explored.Method:Data were collected from a randomized controlled trial of patients with major depressive disorder who were treated in a naturalistic primary care setting. Resource use and quality of life were followed during the two-year trial.Results:The mean total cost per patient during two years was KSEK 363 (EUR 38 953). Indirect costs were the most important component (87%), whereas the cost of drugs was minor (4.5%). No significant differences in costs or quality of life between treatment arms or between adherent and non-adherent patients were demonstrated. However, treatment responders had 39% lower total costs per patient and experienced a larger increase in quality of life compared to non-responders.Conclusions:Major depression has high costs for society, primarily due to indirect costs. Treatment responders have considerably lower costs per patient and higher quality of life than non-responders. This indicates that measures to increase response rates are also important from an economic perspective.

scholarly journals The cost of Mental Health Review Tribunals

1994 ◽  
Vol 18 (5) ◽  
pp. 274-276 ◽  
Author(s):  
Stephen Blumenthal ◽  
Simon Wessely
Keyword(s):  
Mental Health ◽  
Indirect Costs ◽  
Total Cost ◽  
Direct And Indirect Costs ◽  
The Cost ◽  
First Time ◽  
Health Review

There has been a substantial increase in the number of Mental Health Review Tribunals (MHRTs) and hence the cost of administering the tribunal system. We report an estimate of the cost of MHRTs taking account, for the first time, of both direct and indirect costs to the various government departments. We estimate that the total cost is currently £12,274,380 per annum.

Economic burden of gastric cancer in the first six months after diagnosis

2019 ◽  
Vol 13 (4) ◽  
pp. 436-446
Author(s):  
Habib Jalilian ◽  
Leila Doshmangir ◽  
Soheila Ajami ◽  
Habibeh Mir ◽  
Yibeltal Siraneh ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Direct Cost ◽  
Economic Burden ◽  
Insurance Coverage ◽  
Total Direct Cost ◽  
Content Type ◽  
Total Cost ◽  
Illness Study ◽  
The Mean ◽  
The Cost

Purpose Gastric cancer is the fourth most common cancer and the leading cause of death after lung cancer in the world. Considering the economic burden of cancers and their impact on household welfare, this study aims to estimate the cost of gastric cancer in Tabriz (Northwest city of Iran) in 2017. Design/methodology/approach This was an incidence-based cost of illness study which was conducted from the perspective of society with a bottom-up costing approach. The inclusion criteria for the study were all patients (n = 118) with gastric cancer at the period of the first six months after diagnosis that 102 patients participated. Data were analyzed using SPSS software version 22. Findings The mean medical direct cost was US$3288.02, 18.19 per cent paid by the patient and 81.81 per cent paid by insurance organizations and governmental subsidies. The estimated out of pocket rate was 18.19 per cent. The mean non-medical direct cost estimated at US$377.54. The mean total direct cost was US$3665.56, 26.61 per cent paid by the patient. The mean indirect cost estimated at US$505.41 and the mean total cost was US$4170.97, 35.5 per cent which imposed on the patient. The mean total cost of gastric cancer within the first six months after diagnosis was equivalent to 0.81 GDP per capita. Originality/value Based on the findings, gastric cancer is a highly costly disease that despite insurance coverage imposes a high economic burden on the patients and their families.

scholarly journals Rehabilitation cost share and cost analysis of traumatic hand injuries: Our single-center results

2021 ◽  
Vol 67 (3) ◽  
pp. 308-314
Author(s):  
Merih Özgen ◽  
Ayşe Merve Aydoğan ◽  
Ali Uygur ◽  
Onur Armağan ◽  
Funda Berkan ◽  
...  
Keyword(s):  
Cost Analysis ◽  
Direct Cost ◽  
Injury Severity ◽  
Indirect Costs ◽  
Hand Injury ◽  
Economic Policies ◽  
Wrist Injuries ◽  
Total Cost ◽  
The Mean ◽  
The Cost

Objectives: This study aims to evaluate the cost expenses and rehabilitation share of hand and/or wrist injuries and to contribute to the development of health and economic policies. Patients and methods: A total of 59 patients (55 males, 4 females; mean age: 39.1±11.3 years; range, 20 to 64 years) who presented with hand and/or wrist injuries between January 2015 and December 2017 were retrospectively reviewed. Demographic data, hand injury information, and the Modified Hand Injury Severity Scores (MHISS) were retrieved from the patient file system. The cost analysis with direct and indirect costs was performed. Results: According to the MHISS, 27.1% of patients had a minor injury, 23.7% had a moderate injury, 18.6% had a severe injury, and 30.5% had a major injury. The mean direct cost of the patients was $726.00±641.87 and the total cost of the indirect cost was $2,776.93±1,619.00. The mean day-off time was 125±68.62 days. Indirect costs accounted for 79% of the total cost. The mean cost of rehabilitation was $150.18±86.88. Rehabilitation costs accounted for 4% of the total cost. There was a positive correlation between the MHISS and direct, indirect and total cost, but not between the MHISS and rehabilitation cost. Conclusion: The proportion of the share allocated to rehabilitation expenditures, which is the subunit of direct cost, is low and not related to the injury severity. The data obtained from the study contributed to the creation of evidence-based health and economic policies. We believe that these data also contribute to the planning of rehabilitation services according to the severity of injury which would improve the quality of life and return to work.

Financial cost of treating out-patients with schizophrenia in Nigeria

1997 ◽  
Vol 171 (4) ◽  
pp. 364-368 ◽  
Author(s):  
Toyin G. Suleiman ◽  
Jude U. Ohaeri ◽  
Rahman A. Lawal ◽  
Adam Y. Haruna ◽  
O. B. Orija
Keyword(s):  
Antipsychotic Drugs ◽  
Indirect Costs ◽  
Financial Cost ◽  
Total Cost ◽  
Duration Of Illness ◽  
Government Hospitals ◽  
Insulin Dependent ◽  
The Mean ◽  
Cost Of Drugs ◽  
The Cost

BackgroundAn assessment of the monetary costs of treating a group of Nigerian out-patients with schizophrenia, in comparison with insulin-dependent diabetics, was made.MethodFifty out-patients with schizophrenia (mean age 42.9) and 40 with diabetes (mean age 41.9), attending government hospitals in Lagos, were assessed at six-monthly intervals, for direct and indirect costs (US$=82 naira; minimum monthly wage=500 naira)ResultsTwenty (40%) of those with schizophrenia and eight (20%) of the diabetics had no income at all. The mean total cost of schizophrenia in six months (2951.4 naira) or US$ 35.9) was significantly less than that of diabetes (11 791 naira or US$ 143). The cost of antipsychotic drugs accounts for 52.8% of the cost of schizophrenia; insulin injections accounted for 92.8% of the total cost of diabetes. Patients with schizophrenia and their relatives suffered significantly more loss of working days. Cost of illness was not significantly correlated with age and duration of illness.ConclusionsBecause of drastic currency devaluation, and lack of disability benefits and nursing homes, the findings contrast with Western reports where cost of drugs constitutes 2–5%, and indirect costs constitute over 50% of the total cost of schizophrenia.

scholarly journals Direct and indirect costs of cluster headache: a prospective analysis in a tertiary level headache centre

2020 ◽  
Author(s):  
Andrea Negro ◽  
Paolo Sciattella ◽  
Valerio Spuntarelli ◽  
Paolo Martelletti ◽  
Francesco Saverio Mennini
Keyword(s):  
Cluster Headache ◽  
Economic Burden ◽  
National Health System ◽  
Indirect Costs ◽  
Chronic Cluster Headache ◽  
Productive Capacity ◽  
Total Cost ◽  
Direct And Indirect Costs ◽  
Headache Centre ◽  
The Impact

Abstract Background: Cluster headache (CH) is the most frequent trigemino-autonomic cephalgia. CH can manifest as episodic (ECH) or chronic cluster headache (CCH) causing significant burden of disease and requiring attack therapy and prophylactic treatment. The few data available on the economic burden of CH come from retrospective studies based on questionnaires, population surveys and medical insurance claims database. Although all these studies showed an important economic burden, they provided different estimates depending on variability of CH awareness and management, healthcare systems, available therapies and use of treatments according to different guidelines.Methods: This prospective study aimed to quantify the total direct and indirect cost of ECH and CCH over a cluster period, both for the patient and for the National Health System (NHS), using data from subjects who consecutively attended an Italian tertiary headache centre between January 1, 2018 and December 31, 2018.Results: A total 109 patients (89 ECH, 19 CCH) were included. Mean attack frequency was 2.3±1.4 per day. Mean total cost of a CH bout was €4,398 per patient and total cost of CCH was 5.4 times higher than ECH (€13,350 vs. €2,487, p < 0.001). Direct costs represented the 72.1% of total cost and were covered for the 94.8% by the NHS. The costs for any item of expense were higher for CCH than for ECH (p < 0.001). Mean indirect costs for a CH bout were €1,226 per patient and were higher for CCH compared to ECH (€3.538 vs. €732), but the difference was not significant. Days with reduced productive capacity impacted for the 64.6% of the total indirect costs. The analysis of the impact CH on work showed that 27%% of patients felt that CH had limited their career, 40% had changed their work pattern, 20% had changed their place of employment and 10% had lost a job due to the disease.Conclusion: Our results provide a valuable estimate of the direct and indirect costs of ECH and CCH in the specific setting of a tertiary headache centre and confirm the high economic impact of CH on both the NHS and patients.

scholarly journals Estimation of the Impact of Foodborne Salmonellosis on Consumer Well-Being in Hungary

2021 ◽  
Vol 18 (19) ◽  
pp. 10131
Author(s):  
Ágnes Vajda ◽  
László Ózsvári ◽  
Dávid Szakos ◽  
Gyula Kasza
Keyword(s):  
Indirect Costs ◽  
Well Being ◽  
Annual Number ◽  
Foodborne Illnesses ◽  
Direct And Indirect Costs ◽  
Salmonella Infections ◽  
Representative Consumer ◽  
Reported Data ◽  
The Cost ◽  
The Impact

In Hungary, salmonellosis is one of the most frequent foodborne illnesses. According to our estimation, based on a representative consumer survey with 1001 respondents, the annual number of salmonellosis cases exceeded 90,000, which was 18 times higher than the officially reported data. Salmonellosis infections impose significant direct and indirect costs to the health care system, to companies (as employers) and to households. This study focused on the cost to households by analysing well-being losses due to Salmonella infections, for which the WTP (willingness-to-pay) method was used. WTP measures the cost that an individual would pay to avoid an undesirable harm or health outcome. For estimating WTP, 456 respondents gave quantifiable answers. The average WTP to avoid salmonellosis was 86.3 EUR. Based on this data, the total consumer well-being loss could be estimated to be about 7.87 million EUR per year in Hungary. These results indicate that consumers’ well-being losses alone would necessitate further interventions for Salmonella reduction.

A microcosting analysis of ICU expenditure in the interval between brain death and organ donation

2021 ◽  
Vol 23 (2) ◽  
pp. 211-214
Author(s):  
Meghan K Bowtell ◽  
◽  
Melissa J Ankravs ◽  
Timothy Fazio ◽  
Jeffrey J Presneill ◽  
...  
Keyword(s):  
Brain Death ◽  
Organ Donation ◽  
Indirect Costs ◽  
Organ Donors ◽  
Total Cost ◽  
Median Proportion ◽  
The Mean ◽  
The Cost ◽  
Death Care

OBJECTIVE: The cost of providing care in an intensive care unit (ICU) after brain death to facilitate organ donation is unknown. The objective of this study was to estimate expenditure for the care delivered in the ICU between the diagnosis of brain death and subsequent organ donation. DESIGN: Cohort study of direct and indirect costs using bottom-up and top-down microcosting techniques. SETTING: Single adult ICU in Australia. PARTICIPANTS: All patients who met criteria for brain death and proceeded to organ donation during a 13-month period between 1 January 2018 and 31 January 2019. MAIN OUTCOME MEASURES: A comprehensive cost estimate for care provided in the ICU from determination of brain death to transfer to theatre for organ donation. RESULTS: Forty-five patients with brain death became organ donors during the study period. The mean duration of post-death care in the ICU was 37.9 hours (standard deviation [SD], 16.5) at a mean total cost of $7520 (SD, $3136) per donor. ICU staff salaries were the greatest contributor to total costs, accounting for a median proportion of 0.72 of total expenditure (interquartile range, 0.68–0.75). CONCLUSIONS: Substantial costs are incurred in ICU for the provision of patient care in the interval between brain death and organ donation.

Sign in / Sign up

Export Citation Format

Share Document